Basel Medical Group Aktie
Marktkapitalisierung
0 $
0 $
Streubesitz
45,35%
KGV
-3,55
Index-Zuordnung
-
Bilanz/GuV
| Fiskaljahr (Ende: Juni) | 2021/2022 | 2022/2023 | 2023/2024 | 2024/2025 | 2025/2026 |
|---|---|---|---|---|---|
| EBITDA in Mio. | |||||
| EBITDA in Mio. | 3 SGD | 3 SGD | 3 SGD | -11 SGD | - |
| 1. Quartal | |||||
| 1. Quartal | - | - | - | - | - |
| 2. Quartal | |||||
| 2. Quartal | - | - | - | - | - |
| 3. Quartal | |||||
| 3. Quartal | - | - | - | - | - |
| 4. Quartal | |||||
| 4. Quartal | - | - | - | - | - |
| Operatives Ergebnis (EBIT) in Mio. | |||||
| Operatives Ergebnis (EBIT) in Mio. | 2 SGD | 2 SGD | 3 SGD | -2 SGD | - |
| 1. Quartal | |||||
| 1. Quartal | - | - | - | - | - |
| 2. Quartal | |||||
| 2. Quartal | - | - | - | - | - |
| 3. Quartal | |||||
| 3. Quartal | - | - | - | - | - |
| 4. Quartal | |||||
| 4. Quartal | - | - | - | - | - |
| Finanzergebnis in Mio. | |||||
| Finanzergebnis in Mio. | 6 SGD | 5 SGD | 6 SGD | 11 SGD | - |
| Ergebnis vor Steuern (EBT) in Mio. | |||||
| Ergebnis vor Steuern (EBT) in Mio. | 2 SGD | 2 SGD | 2 SGD | -13 SGD | - |
| 1. Quartal | |||||
| 1. Quartal | - | - | - | - | - |
| 2. Quartal | |||||
| 2. Quartal | - | - | - | - | - |
| 3. Quartal | |||||
| 3. Quartal | - | - | - | - | - |
| 4. Quartal | |||||
| 4. Quartal | - | - | - | - | - |
| Steuern auf Einkommen und Ertrag in Mio. | |||||
| Steuern auf Einkommen und Ertrag in Mio. | 0 SGD | 0 SGD | 0 SGD | -0 SGD | - |
| Ergebnis nach Steuer in Mio. | |||||
| Ergebnis nach Steuer in Mio. | 2 SGD | 2 SGD | 2 SGD | -12 SGD | - |
| 1. Quartal | |||||
| 1. Quartal | - | - | - | - | - |
| 2. Quartal | |||||
| 2. Quartal | - | - | - | - | - |
| 3. Quartal | |||||
| 3. Quartal | - | - | - | - | - |
| 4. Quartal | |||||
| 4. Quartal | - | - | - | - | - |
| Nettogewinn/-verlust in Mio. | |||||
| Nettogewinn/-verlust in Mio. | - | - | - | - | - |
Aktiva
| Fiskaljahr (Ende: Juni) | 2021/2022 | 2022/2023 | 2023/2024 | 2024/2025 | 2025/2026 |
|---|---|---|---|---|---|
| Umlaufvermögen in Mio. | |||||
| Umlaufvermögen in Mio. | 16 SGD | 15 SGD | 16 SGD | 13 SGD | - |
| 1. Quartal | |||||
| 1. Quartal | - | - | - | - | 13 $ |
| 2. Quartal | |||||
| 2. Quartal | - | - | 16 SGD | 14 SGD | - |
| 3. Quartal | |||||
| 3. Quartal | - | - | - | - | - |
| 4. Quartal | |||||
| 4. Quartal | - | 15 SGD | 16 SGD | 13 SGD | - |
| Anlagevermögen in Mio. | |||||
| Anlagevermögen in Mio. | 1 SGD | 1 SGD | 0 SGD | 4 SGD | - |
| Aktiva in Mio. | |||||
| Aktiva in Mio. | 17 SGD | 15 SGD | 16 SGD | 17 SGD | - |
Passiva
| Fiskaljahr (Ende: Juni) | 2021/2022 | 2022/2023 | 2023/2024 | 2024/2025 | 2025/2026 |
|---|---|---|---|---|---|
| kurzfristiges Fremdkapital in Mio. | |||||
| kurzfristiges Fremdkapital in Mio. | 7 SGD | 6 SGD | 7 SGD | 11 SGD | - |
| langfristiges Fremdkapital in Mio. | |||||
| langfristiges Fremdkapital in Mio. | 6 SGD | 3 SGD | 2 SGD | 1 SGD | - |
| Fremdkapital in Mio. | |||||
| Fremdkapital in Mio. | 13 SGD | 10 SGD | 9 SGD | 12 SGD | - |
| 1. Quartal | |||||
| 1. Quartal | - | - | - | - | 12 $ |
| 2. Quartal | |||||
| 2. Quartal | - | - | 10 SGD | 8 SGD | - |
| 3. Quartal | |||||
| 3. Quartal | - | - | - | - | - |
| 4. Quartal | |||||
| 4. Quartal | - | 10 SGD | 9 SGD | 13 SGD | - |
| Minderheitenanteil in Mio. | |||||
| Minderheitenanteil in Mio. | 0 SGD | 0 SGD | 0 SGD | 0 SGD | - |
| Eigenkapital in Mio. | |||||
| Eigenkapital in Mio. | 4 SGD | 5 SGD | 8 SGD | 5 SGD | - |
| 1. Quartal | |||||
| 1. Quartal | - | - | - | - | 5 $ |
| 2. Quartal | |||||
| 2. Quartal | - | - | 7 SGD | 7 SGD | - |
| 3. Quartal | |||||
| 3. Quartal | - | - | - | - | - |
| 4. Quartal | |||||
| 4. Quartal | - | 5 SGD | 8 SGD | 5 SGD | - |
| Passiva in Mio. | |||||
| Passiva in Mio. | 17 SGD | 15 SGD | 16 SGD | 17 SGD | - |
Quelle: Leeway